DIDMOAD is a dubious disease in the field of genetic metabolism, with complex clinical manifestations and often involving multi-systemic strain. Early identification and standardized diagnosis are critical to improving prognosis. Diagnosis of the disease requires a combination of clinical manifestations, imaging checks, laboratory checks and pathological evaluations.
The platform can assist in matching a team of authoritative experts at home and abroad to provide accurate diagnosis and treatment programs. In recent years, with the development of therapeutic, immune-regulated therapy and precision medicine, many previously difficult-to-treat genetic metabolic diseases have been significantly improved. Treatment needs to be closely monitored for efficacy and adverse reactions, adjusted in a timely manner depending on the changes in the disease.
Multidisciplinary collaboration (MDT) is particularly important for the comprehensive management of Wolfram syndrome DIDMOAD. The platform serves a team of domestically authoritative experts in the field of genetic metabolism in China's international medical service system, providing the following services to patients: 2. Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment programs; 3.
Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.